No it is not all patients alike, of course. When you stop and think about it, how is a patient to respond with any sense of intelligence when being blasted with a diagnosis of breast cancer and striving to determine whether their heirs had BRCA1 or BRCA2 gene? Yet that is the line in the sand to determine the most effective treatment for individual patients. It is mind boggling, to say the least. In America we each need to decide what pathway is best for us, an incredible responsibility when making health care decisions.
So again, I think Matt is doing the right thing by creating the infrastructure. It just may be a few years until public perception catches up with available technology. All good IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.